Chair of the ENTIS Scientific Committee, Prof Per Damkier, and the Head of UKTIS, Dr Ken Hodson, have published an opinion piece in the Obstetric Medicine journal challenging the findings of a 2021 consensus statement published in Nature Reviews Endocrinology. More information can be found here. Photo by James Yarema on Unsplash
» Read more
Researchers from Ammon Pinizzotto Center for Women’s Mental Health (Boston, MA, USA), have published a small case series of first trimester buspirone-exposed pregnancies. More information can be found here. Photo by Joice Kelly on Unsplash
» Read more
Researchers from the Kerala Registry of epilepsy and pregnancy have published an update of their dataset describing the neurodevelopmental attainment of children of women with epilepsy. More information can be found here. Photo by JESHOOTS.COM on Unsplash
» Read more
In March 2022 the European Medicines Agency’s (EMA) published a direct healthcare professional communication (DHPC) regarding the use of live vaccines in infants exposed to infliximab in utero or during breastfeeding. The DHPC stated that live vaccines (e.g. BCG vaccine) should not be given to infants less than 12 months after birth following in utero infliximab exposure, and that administration […]
» Read more
Researchers from the ENTIS affiliated Swiss Teratogen Information Service (STIS) have published details about the clinical queries raised to the on medication use in pregnancy to the service over the last 20 years. More information can be found here. Photo by Julian Hochgesang on Unsplash.
» Read more
ENTIS affiliated researchers from the Department of Pharmaceutical and Pharmacological Sciences, KU Leuven have published a case report of bosentan and sildenafil use in lactation. This report, from the IMI ConcePTION project, presents the clinical and pharmacokinetic data of a single mother-infant pair exposed to bosentan and sildenafil for the treatment of pulmonary arterial hypertension (PAH) during lactation. More information […]
» Read more
ENTIS affiliated researchers from the Pharmacoepidemiology and Drug Safety Research Group, , PharmaTox Research Initiative at the University of Oslo have published a study investigating whether an association exists between maternal use of triptans during pregnancy and diagnosis or symptoms of attention-deficit hyperactivity disorder among their offspring. More information can be found here. Photo by Anthony Tran on Unsplash
» Read more
JAMA Neurology have recently published a population-based cohort study which used health and social register data from Denmark, Finland, Iceland, Norway, and Sweden to investigate neurodevelopmental outcomes of children (up to age 8) exposed to antiseizure medications in pregnancy. Increased risks of autism spectrum disorder and intellectual disability were observed for children exposed to topiramate in utero. More information can […]
» Read more
ENTIS affiliated researchers operating the Swiss COVI-PREG registry have published a multicentre prospective cohort study describing early adverse events and perinatal outcomes in pregnant women who received at least one dose of mRNA vaccine in Switzerland (n=1,012 pregnancies). More information can be found here.
» Read more
ENTIS affiliated researchers from the Terafar; Izmir Katip Celebi University Teratology Information, Training and Research Center in Turkey, have published a systematic review and meta-analysis of pregnancy outcomes following maternal exposure to statins. More information can be found here. Photo by Christine Sandu on Unsplash
» Read more